Home › Rhabdomyosarcoma › Massachusetts › Boston
Rhabdomyosarcoma clinical trials in Boston, MA
3 studies for Rhabdomyosarcoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
RecruitingPhase 1/2
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
RecruitingPhase 3
- Dana-Farber Cancer Institute, Boston
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
RecruitingPhase 1/2
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Brigham and Women's Hospital, Boston
Rhabdomyosarcoma trials in other cities
- Memphis, TN6 studies
- Houston, TX5 studies
- Washington, DC5 studies
- Salt Lake City, UT4 studies
- Birmingham, AL3 studies
- Dallas, TX3 studies
- Milwaukee, WI3 studies
- Philadelphia, PA3 studies
- Mountain View, CA3 studies
- The Bronx, NY3 studies
- Aurora, CO3 studies
- Baltimore, MD3 studies
Other studies in Boston
- Breast Cancer110 studies
- Cancer (all types)90 studies
- Non-Small Cell Lung Cancer87 studies
- Lung Cancer63 studies
- Colorectal Cancer62 studies
- Ovarian Cancer62 studies
- Metastatic Cancer61 studies
- Prostate Cancer56 studies
- Endometrial Cancer51 studies
- Depression50 studies
- Heart Failure46 studies
- Multiple Myeloma45 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.